Literature DB >> 30384892

Angiotensin Receptor-Neprilysin Inhibitors Emerge as Potential Treatment for Acute Myocardial Infarction.

David J Lefer1, Thomas E Sharp2.   

Abstract

Entities:  

Keywords:  LCZ696; acute myocardial infarction; preclinical translational research

Mesh：

Substances：

Year:  2018        PMID： 30384892     DOI： 10.1016/j.jacc.2018.08.2170

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  2 in total

1.  Protection of Sacubitril/Valsartan against Pathological Cardiac Remodeling by Inhibiting the NLRP3 Inflammasome after Relief of Pressure Overload in Mice.

Authors:  Xueling Li; Qin Zhu; Qingcheng Wang; Qinggang Zhang; Yaru Zheng; Lihong Wang; Qinyang Jin
Journal:  Cardiovasc Drugs Ther       Date:  2020-10       Impact factor: 3.727

2.  Clinical outcomes of Sacubitril/Valsartan in patients with acute heart failure: A multi-institution study.

Authors:  Dong-Yi Chen; Chun-Chi Chen; Chi-Nan Tseng; Shao-Wei Chen; Shang-Hung Chang; Wen-Kuan Huang; Ming-Shien Wen; Ming-Jer Hsieh; I-Chang Hsieh
Journal:  EClinicalMedicine       Date:  2021-10-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.